Clinical Trials Listing Service

ASCVD and Lipid Lowering

Last updated: December 13, 2023
Sponsor: N/A
Overall Status: Active - Recruiting

Phase

N/A

Condition

Sinusitis

Treatment

N/A

Clinical Study ID

TX322054
  • Ages 18-150
  • All Genders

Study Summary

A clinical research study is evaluating an investigational medicine added to statin therapy that may help reduce the risk of future cardiovascular events (heart attack and stroke).

Eligibility Criteria

Inclusion

Inclusion Criteria

Participation Eligibility

  • 18 years of age or older
  • Have had a heart attack, stroke, or symptomatic blockage in the arteries of the lower extremities

OR

  • Have ASCVD risk factors (e.g. hypertension, vascular disease, kidney disease, etc. )
  • Additional qualification criteria exist

Study Design

Study Start date:
Estimated Completion Date:

Study Description

We are seeking participants for a clinical study to evaluate the impact of an investigational mediation on adults with who have Atherosclerotic Cardiovascular Disease (ASCVD) and high cholesterol.

The goal of this study is to determine the investigational medications effect on lowering cholesterol as well as reducing the risk of cardiovascular events in individuals with ASCVD event history.

Connect with a study center

  • Chase Medical Research

    Waterbury, CT 06708
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.